32
Views
20
CrossRef citations to date
0
Altmetric
Commentaries

The IARC Monographs Program: Changing Attitudes towards Public Health

Pages 144-152 | Published online: 20 Nov 2013

References

  • Tomatis L, Huff J. Evolution of research in cancer etiology. In: Coleman WB, Tsongalis GJ ( eds). The Molecular Basis of Human Cancer. Totowa, NJ: Humana Press, 2002, 1989-201.
  • Hueper WC, Conway WD. Chemical Carcinogenesis and Can-cers. Springfield, IL: Charles C Thomas, 1964.
  • World Health Organization. Prevention of Cancer. Technical Report Series 276. Geneva, Switzerland: WHO, 1964.
  • Agthe C, Tomatis L. Evaluation of the carcinogenicity of envi-ronmental chemicals and the possibility of cancer prevention. In: Homburger F ( ed). The Physiopathology of Cancer. Basel, Switzerland: Karger, 1976: 245-58.
  • IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. Vol 1. Lyon, France: IARC, 1972.
  • IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. Vol 2. Lyon, France: IARC, 1973.
  • IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 23. Lyon, France: IARC, 1980.
  • IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 58. Lyon, France: IARC, 1993.
  • IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. Vol 14. Lyon, France: IARC, 1977.
  • IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Suppl 4. Lyon, France: IARC, 1982.
  • IARC Monographs on the Evaluation of Carcinogenic Risk s to Humans. Suppl 7. Lyon, France: IARC, 1987.
  • Berenblum I. The mechanism of carcinogenesis: study of the significance of carcinogenic action and related phenomena. Cancer Res. 1941; 1: 897–914.
  • Berenblum I, Shubik P. A new quantitative approach to the study of the stages of chemical carcinogenesis in the mouse's skin. Br J Cancer. 1947; 1: 383–91.
  • Bradford Hill A. The environment and disease: association or causation? Proc R Soc Med. 1965; 56: 295–300.
  • Bradford Hill A. Principles of Medical Statistics. London, U.K.: The Lancet Ltd, 1971.
  • Passey RD. Experimental soot cancer. BMJ, 1922;ii:1112–3.
  • Tomatis L. The predictive value of rodent carcinogenicity tests in the evaluation of human risks. Annu Rev Pharmacol Toxicol. 1979; 19: 11–30.
  • Huff J. Chemicals and cancer in humans: first evidence in ex-perimental animals. Environ Health Perspect. 1993;100;201–10.
  • Maltoni C, Conti B, Cotti G. Benzene: a multi-potential carcino-gen. Results of long-term bioassays performed at the Bologna Institute of Oncology. Arn J Ind Med. 1983; 4: 589–630.
  • Van Duuren BL, Goldschmidt BM, Katz C, Langseth L, Mercado G, Siwak A. Alpha-haloethers: a new type of alkylating carcino-gen. Arch Environ Health. 1968; 16: 472–9.
  • Laskin S, Kushner M, Drew RT, Cappiello VP, Nelson N. Tumors of the respiratory tract induced by inhalation of bis(chloro-methyl) ether. Arch Environ Health. 1971; 23: 135–40.
  • Tomatis L, Agthe C, Bartsch H, et al. Evaluation of the carcino-genicity of chemicals: a review of the Monographs program of the International Agency for Research on Cancer (1971-1977). Cancer Res. 1978; 38: 877–85.
  • Kourilsky P, Viney G. E Principe de Precaution. Paris, France: Odile Jacob, 2000.
  • Kriebel D, Tickner J, Epstein P, et al. The precautionary princi-ple in environmental science. Environ Health Perspect. 2001; 109: 871–6.
  • Lilienfeld DE. The silence: the asbestos industry and early occu-pational cancer research-a case study, Am J Public Health. 1991; 81: 791-800
  • Castleman BI. Asbestos and cancer: history and public policy. Br J Ind Med. 1991; 48: 427–32.
  • Markowitz G, Rosner D. Deceit and Denial: The Deadly Politics of Industrial Pollution. Berkeley, CA: University of California Press/Milbank Fund, 2002 (in press).
  • Higginson J. DDT: epidemiological evidence. In: Wald NJ, Doll R ( eds). Interpretation of Negative Epidemiological Evidence for Carcinogenicity. Lyon, France: IARC, 1985: 107-17.
  • Rehn L. Bladder tumours in fuchsin workers. Arch Klin Chin 1895; 50: 588–600.
  • International Labor Office. Cancer of the Bladder among Workers in Aniline Factories. Studies and Report, Series F, No. 1. Geneva, Switzerland: ILO, 1921.
  • Montesano R, Tomatis L. Legislation concerning chemical car-cinogens in several industrialized countries. Cancer Res. 1977; 37: 310–6.
  • Lanes SF. Error and uncertainty in causal inference. In: Roth-man KJ (ed). Causal Inference. Springfield, MA: Epidemiology Resources Inc., 1988, 173-88.
  • IARC. Approaches to Classifying Chemical Carcinogens Accord-ing to Mechanism of Action. IARC Internal Technical Report No. 83/001. Lyon, France: IARC, 1983.
  • IARC. Mechanisms of Carcinogenesis in Risk Identification. A Consensus Report of an IARC Monographs Working Group. IARC Internal Technical Report No. 91/002. Lyon, France: IARC, 1991.
  • Vainio H, Magee PN, McGregor DB, McMichael AJ. Mecha-nisms of Carcinogenicity in Risk Identification. IARC Scientific Publications No. 116. Lyon, France: IARC, 1992.
  • IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 60. Lyon, France: IARC, 1994.
  • IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 69. Lyon, France: IARC, 1997.
  • IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 71. Lyon, France: IARC, 1999.
  • National Toxicology Program, Ninth Report on Carcinogens. Department of Health and Human Services, National Institute for Environmental Health Sciences, Research Triangle Park, NC, 2000.
  • IARC Monographs on the Evaluation of Carcinogenic Riskls to Humans. Vol 73. Lyon, France: IARC, 1999.
  • IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 77. Lyon, France: IARC, 2000.
  • IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 81. Lyon, France: IARC (in press).
  • IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 53. Lyon, France: IARC, 1991.
  • IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. Vol 22. Lyon, France: IARC, 1980.
  • American Industrial Health Council. Determining Modes of Action for Biologically Based Risk Assessments. Washington, DC: AIHC, 1999.
  • IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 29. Lyon, France: IARC, 1982.
  • IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. Vol 7. Lyon, France: IARC, 1974.
  • IARC Monographs on the Evaluation of Carcinogenic Risks of Chemicals to Humans. Vol 41. Lyon, France: IARC, 1986.
  • IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 79. Lyon, France: IARC, 2001.
  • Capen CC, Dybing E, Rice JM, Wilbourn JD (eds). Species Dif-ferences in Thyroid, Kidney and Urinary Bladder Carcinogene-sis. IARC Scientific Publications. No. 147. Lyon, France: IARC, 1999.
  • Karstadt M, Haseman JK. Effect of discontinuing certain tumor types/sites on evaluations of carcinogenicity in laboratory ani-mals. Am J Ind Med. 1997; 31: 485–94.
  • Environmental Protection Agency. Proposed guidelines for car-cinogenic risk assessment, notice of availability and opportunity to comment on proposed guidelines for carcinogen risk assess-ment. Fed Reg. 1996; 61: 17959-8011.
  • IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans. Vol 43. Lyon, France: IARC, 1988.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.